Genmab A/S Files March 2025 6-K Report
Ticker: GNMSF · Form: 6-K · Filed: Mar 12, 2025 · CIK: 1434265
| Field | Detail |
|---|---|
| Company | Genmab A/S (GNMSF) |
| Form Type | 6-K |
| Filed Date | Mar 12, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, sec-filing
TL;DR
Genmab filed its March 6-K, check the S-8 filings for details.
AI Summary
Genmab A/S filed a Form 6-K on March 12, 2025, to report information for the month of March 2025. This filing is incorporated by reference into several of Genmab's S-8 registration statements, including File No. 333-284876.
Why It Matters
This filing serves as an update for investors and indicates ongoing reporting requirements for Genmab A/S with the SEC.
Risk Assessment
Risk Level: low — This is a routine reporting form (6-K) that incorporates previous filings and does not appear to contain new material financial or operational information.
Key Players & Entities
- Genmab A/S (company) — Registrant
- 0001558370-25-002768 (filing_id) — Accession Number
- 20250312 (date) — Filing Date
- 333-232693 (registration_statement_id) — Incorporated by reference in S-8 registration statement
- 333-284876 (registration_statement_id) — Incorporated by reference in S-8 registration statement
FAQ
What type of report is Genmab A/S filing?
Genmab A/S is filing a Form 6-K report.
What is the filing date of this Form 6-K?
The filing date is March 12, 2025.
What period does this report cover?
This report is for the month of March 2025.
Which registration statements does this 6-K filing get incorporated into?
This 6-K filing is incorporated by reference into Genmab A/S's registration statements on Form S-8, including File Nos. 333-232693, 333-253519, 333-262970, 333-277273, and 333-284876.
What is the principal executive office address for Genmab A/S?
The principal executive office address is Carl Jacobsens Vej 30, 2500 Valby, Denmark.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on March 12, 2025 regarding GENMAB A/S (GNMSF).